FDA Inspection
Aurobindo Pharma LimitedAurobindo Pharma Limited – FDA Inspection, Sep 17, 2010
Record Details
This FDA Inspection record concerns Aurobindo Pharma Limited, with an inspection on September 17, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Aurobindo Pharma Limited
- Inspection Date
- September 17, 2010
- Product Type
- Drugs
View Company Profile
ID · 9cf54b3a-8e21-4051-b7ac-26a4ad57dcff
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 684549
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Aurobindo Pharma Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 5, 2025 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 9, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 21, 2020 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| March 16, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 16, 2013 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Aurobindo Pharma Limited
- FDA Inspection 1286862 - 2025-09-05
- FDA Inspection 1241780 - 2023-03-09
- FDA Inspection 1118385 - 2020-02-21
- FDA Inspection 1046218 - 2018-03-16
- FDA Inspection 847151 - 2013-08-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.